// App-Quantinova.ai

e16563 : Baseline genomic and circulating tumor cell (CTC) correlative data from very high-risk (VHR), localized, node-negative prostate cancer patients.

Researchers

Presenter

  • Sean Matthew McBride

Principal Investigators

  • Michael J. Zelefsky

  • Daniel Eidelberg Spratt

  • Channing Judith Paller

  • Marisa Kollmeier

  • Susan F. Slovin

  • Jahan Aghalar

  • Jason W.D. Hearn

  • Robert Benjamin Den

  • Curtiland Deville

  • Han Xiao

  • Wassim Abida

  • Howard I. Scher

  • Dana E. Rathkopf

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • University of Michigan, Ann Arbor, MI

  • Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • CB-7598

  • Leuprolide acetate

Outcome

  • N/A

Study Design

  • Single Arm

Phase

  • II

Study Id's

  • NCT02772588

Sponsors

  • Janssen Pharmaceutical

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved